Skip to main content
MediciNova,Inc. logo

MediciNova,Inc. — Investor Relations & Filings

Ticker · 4875 ISIN · US58468P2065 T Manufacturing
Filings indexed 59 across all filing types
Latest filing 2019-06-12 Annual Report
Country JP Japan
Listing T 4875

About MediciNova,Inc.

https://medicinova.com/

MediciNova, Inc. is a clinical-stage biopharmaceutical company that acquires and develops novel, small-molecule therapeutics. The company's late-stage pipeline focuses on addressing unmet medical needs in neurology, respiratory, and liver diseases. Key development programs include MN-166 (ibudilast) for neurological conditions, MN-001 (tipelukast) for fibrotic diseases such as liver fibrosis (NASH) and pulmonary fibrosis (IPF), and MN-221 for respiratory conditions including acute exacerbations of asthma and COPD.

Recent filings

Filing Released Lang Actions
有価証券報告書
Annual Report Classification · 100% confidence The document is a comprehensive 'Annual Securities Report' (有価証券報告書) filed in Japan by MediciNova, Inc. It includes the auditor's consent, the audit report from BDO USA, LLP, and detailed corporate information, governance, and financial disclosures for the fiscal year ended December 31, 2018. As it contains full financial statements and substantive management analysis for the fiscal year, it is classified as an Annual Report (10-K equivalent). FY 2018
2019-06-12 Japanese
四半期報告書
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, as indicated by the header and the legal reference (Financial Instruments and Exchange Act). It contains detailed financial data, management discussion, and business analysis for the period ending September 30, 2018. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q3 2018
2018-12-12 Japanese
四半期報告書
Interim / Quarterly Report Classification · 100% confidence The document is a '四半期報告書' (Quarterly Report) filed by MediciNova, Inc. with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements, management analysis, and business information for the period ending June 30, 2018. It meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Q2 2018
2018-09-12 Japanese
四半期報告書
Interim / Quarterly Report Classification · 100% confidence The document is a '四半期報告書' (Quarterly Report) filed with the Kanto Local Finance Bureau in Japan by MediciNova, Inc. It contains detailed financial data, management analysis, and business descriptions for the period from January 1, 2018, to March 31, 2018. This fits the definition of an Interim/Quarterly Report (IR). Q1 2018
2018-06-13 Japanese
有価証券報告書
Annual Report Classification · 100% confidence The document is a comprehensive 'Annual Securities Report' (有価証券報告書) for MediciNova, Inc. for the fiscal year ended December 31, 2017. It includes the auditor's consent, the audit report from BDO USA, LLP, and detailed corporate information, governance, and financial disclosures required by Japanese regulatory law (Financial Instruments and Exchange Act). As it contains the full annual financial statements and management analysis for the fiscal year, it is classified as an Annual Report (10-K equivalent). FY 2017
2018-06-11 Japanese
四半期報告書
Interim / Quarterly Report Classification · 100% confidence The document is a '四半期報告書' (Quarterly Report) filed with the Kanto Local Finance Bureau in Japan by MediciNova, Inc. It contains detailed financial data, including balance sheets, income statements, and cash flow statements for the quarterly period ending September 30, 2017. It also includes management's discussion and analysis of the business and financial condition. As it is a comprehensive financial report for a period shorter than a full fiscal year containing substantive financial data, it is classified as an Interim/Quarterly Report. Q3 2017
2017-12-12 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.